Annual EBIT
-$5.00 M
+$2.68 M+34.86%
December 1, 2023
Summary
- As of February 7, 2025, NBY annual earnings before interest & taxes is -$5.00 million, with the most recent change of +$2.68 million (+34.86%) on December 1, 2023.
- During the last 3 years, NBY annual EBIT has risen by +$1.42 million (+22.14%).
- NBY annual EBIT is now -282.59% below its all-time high of $2.74 million, reached on December 31, 2009.
Performance
NBY EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBIT
-$1.07 M
+$211.00 K+16.42%
September 1, 2024
Summary
- As of February 7, 2025, NBY quarterly earnings before interest & taxes is -$1.07 million, with the most recent change of +$211.00 thousand (+16.42%) on September 1, 2024.
- Over the past year, NBY quarterly EBIT has dropped by -$376.00 thousand (-53.87%).
- NBY quarterly EBIT is now -131.27% below its all-time high of $3.44 million, reached on December 31, 2009.
Performance
NBY Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBIT
-$6.75 M
-$376.00 K-5.90%
September 1, 2024
Summary
- As of February 7, 2025, NBY TTM earnings before interest & taxes is -$6.75 million, with the most recent change of -$376.00 thousand (-5.90%) on September 1, 2024.
- Over the past year, NBY TTM EBIT has dropped by -$790.00 thousand (-13.26%).
- NBY TTM EBIT is now -345.42% below its all-time high of $2.75 million, reached on December 31, 2009.
Performance
NBY TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
NBY EBIT Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +34.9% | -53.9% | -13.3% |
| 3 y3 years | +22.1% | +12.5% | -18.0% |
| 5 y5 years | +36.4% | +12.5% | -18.0% |
NBY EBIT Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +43.5% | -135.0% | +66.4% | -34.9% | +32.6% |
| 5 y | 5-year | at high | +46.8% | -135.0% | +66.4% | -34.9% | +32.6% |
| alltime | all time | -282.6% | +76.3% | -131.3% | +82.9% | -345.4% | +68.1% |
NovaBay Pharmaceuticals EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$1.07 M(-16.4%) | -$6.75 M(+5.9%) |
| Jun 2024 | - | -$1.28 M(-51.6%) | -$6.37 M(+0.9%) |
| Mar 2024 | - | -$2.66 M(+53.3%) | -$6.32 M(+26.2%) |
| Dec 2023 | -$5.00 M(-34.9%) | -$1.73 M(+148.3%) | -$5.00 M(-16.0%) |
| Sep 2023 | - | -$698.00 K(-43.1%) | -$5.96 M(+4.2%) |
| Jun 2023 | - | -$1.23 M(-8.8%) | -$5.72 M(-13.9%) |
| Mar 2023 | - | -$1.34 M(-50.0%) | -$6.64 M(-13.5%) |
| Dec 2022 | -$7.68 M(-13.3%) | -$2.69 M(+488.4%) | -$7.68 M(-6.2%) |
| Sep 2022 | - | -$457.00 K(-78.8%) | -$8.19 M(-18.3%) |
| Jun 2022 | - | -$2.15 M(-9.7%) | -$10.02 M(+3.0%) |
| Mar 2022 | - | -$2.38 M(-25.4%) | -$9.72 M(+9.7%) |
| Dec 2021 | -$8.86 M(+37.9%) | -$3.19 M(+39.5%) | -$8.86 M(+19.3%) |
| Sep 2021 | - | -$2.29 M(+23.1%) | -$7.43 M(+3.2%) |
| Jun 2021 | - | -$1.86 M(+22.3%) | -$7.20 M(+12.3%) |
| Mar 2021 | - | -$1.52 M(-13.5%) | -$6.41 M(-0.2%) |
| Dec 2020 | -$6.43 M(-31.6%) | -$1.76 M(-14.7%) | -$6.43 M(-7.0%) |
| Sep 2020 | - | -$2.06 M(+92.5%) | -$6.91 M(+5.3%) |
| Jun 2020 | - | -$1.07 M(-30.2%) | -$6.56 M(-4.5%) |
| Mar 2020 | - | -$1.53 M(-31.4%) | -$6.86 M(-27.0%) |
| Dec 2019 | -$9.40 M(+19.4%) | -$2.24 M(+30.7%) | -$9.40 M(+7.1%) |
| Sep 2019 | - | -$1.71 M(+24.1%) | -$8.77 M(-1.1%) |
| Jun 2019 | - | -$1.38 M(-66.1%) | -$8.87 M(-7.4%) |
| Mar 2019 | - | -$4.07 M(+152.7%) | -$9.57 M(+21.6%) |
| Dec 2018 | -$7.87 M(+7.7%) | -$1.61 M(-10.9%) | -$7.87 M(+34.1%) |
| Sep 2018 | - | -$1.81 M(-13.2%) | -$5.87 M(-5.8%) |
| Jun 2018 | - | -$2.08 M(-12.0%) | -$6.23 M(+5.5%) |
| Mar 2018 | - | -$2.37 M(-704.1%) | -$5.90 M(-19.3%) |
| Dec 2017 | -$7.31 M(-33.4%) | $392.00 K(-118.1%) | -$7.31 M(-24.9%) |
| Sep 2017 | - | -$2.17 M(+23.4%) | -$9.73 M(+1.1%) |
| Jun 2017 | - | -$1.76 M(-53.5%) | -$9.63 M(-4.8%) |
| Mar 2017 | - | -$3.78 M(+86.1%) | -$10.11 M(-8.0%) |
| Dec 2016 | -$10.98 M(-48.0%) | -$2.03 M(-1.5%) | -$10.98 M(-27.8%) |
| Sep 2016 | - | -$2.06 M(-8.0%) | -$15.22 M(-17.8%) |
| Jun 2016 | - | -$2.24 M(-51.8%) | -$18.51 M(-12.4%) |
| Mar 2016 | - | -$4.65 M(-25.8%) | -$21.13 M(-0.0%) |
| Dec 2015 | -$21.14 M(+25.0%) | -$6.27 M(+17.2%) | -$21.14 M(+6.8%) |
| Sep 2015 | - | -$5.35 M(+10.1%) | -$19.80 M(+6.7%) |
| Jun 2015 | - | -$4.86 M(+4.2%) | -$18.56 M(+6.1%) |
| Mar 2015 | - | -$4.66 M(-5.4%) | -$17.49 M(+3.4%) |
| Dec 2014 | -$16.90 M | -$4.93 M(+19.8%) | -$16.90 M(+0.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2014 | - | -$4.11 M(+8.6%) | -$16.84 M(+7.2%) |
| Jun 2014 | - | -$3.79 M(-7.2%) | -$15.71 M(-2.3%) |
| Mar 2014 | - | -$4.08 M(-16.2%) | -$16.08 M(+3.8%) |
| Dec 2013 | -$15.49 M(+86.4%) | -$4.87 M(+63.2%) | -$15.48 M(+15.0%) |
| Sep 2013 | - | -$2.98 M(-28.1%) | -$13.46 M(+27.2%) |
| Jun 2013 | - | -$4.15 M(+19.0%) | -$10.59 M(+13.7%) |
| Mar 2013 | - | -$3.49 M(+22.7%) | -$9.31 M(+12.1%) |
| Dec 2012 | -$8.31 M(+92.3%) | -$2.84 M(+2581.1%) | -$8.31 M(+4.7%) |
| Sep 2012 | - | -$106.00 K(-96.3%) | -$7.93 M(-3.0%) |
| Jun 2012 | - | -$2.88 M(+15.7%) | -$8.18 M(+68.2%) |
| Mar 2012 | - | -$2.48 M(+0.7%) | -$4.86 M(+12.5%) |
| Dec 2011 | -$4.32 M(-4.3%) | -$2.47 M(+609.2%) | -$4.32 M(+125.9%) |
| Sep 2011 | - | -$348.00 K(-179.1%) | -$1.91 M(-40.4%) |
| Jun 2011 | - | $440.00 K(-122.6%) | -$3.21 M(-33.7%) |
| Mar 2011 | - | -$1.95 M(+3141.7%) | -$4.84 M(+7.2%) |
| Dec 2010 | -$4.52 M(-264.8%) | -$60.00 K(-96.4%) | -$4.52 M(+342.3%) |
| Sep 2010 | - | -$1.65 M(+38.1%) | -$1.02 M(-290.5%) |
| Jun 2010 | - | -$1.19 M(-26.3%) | $536.00 K(-63.0%) |
| Mar 2010 | - | -$1.62 M(-147.1%) | $1.45 M(-47.3%) |
| Dec 2009 | $2.74 M(-132.2%) | $3.44 M(-3959.6%) | $2.75 M(-188.5%) |
| Sep 2009 | - | -$89.00 K(-68.0%) | -$3.11 M(-29.0%) |
| Jun 2009 | - | -$278.00 K(-12.6%) | -$4.37 M(-31.3%) |
| Mar 2009 | - | -$318.00 K(-86.9%) | -$6.36 M(-28.4%) |
| Dec 2008 | -$8.51 M(+44.8%) | -$2.42 M(+78.5%) | -$8.88 M(+10.7%) |
| Sep 2008 | - | -$1.36 M(-40.2%) | -$8.03 M(-3.3%) |
| Jun 2008 | - | -$2.27 M(-20.1%) | -$8.30 M(+7.8%) |
| Mar 2008 | - | -$2.84 M(+81.6%) | -$7.70 M(+31.0%) |
| Dec 2007 | -$5.88 M(+6.3%) | -$1.56 M(-4.0%) | -$5.88 M(-41.5%) |
| Sep 2007 | - | -$1.63 M(-2.5%) | -$10.05 M(+22.4%) |
| Jun 2007 | - | -$1.67 M(+64.5%) | -$8.21 M(+2.2%) |
| Mar 2007 | - | -$1.01 M(-82.3%) | -$8.03 M(-2.5%) |
| Dec 2006 | -$5.53 M(+54.8%) | -$5.73 M(-2856.7%) | -$8.24 M(+144.5%) |
| Sep 2006 | - | $208.00 K(-113.9%) | -$3.37 M(-24.2%) |
| Jun 2006 | - | -$1.49 M(+22.6%) | -$4.44 M(+16.4%) |
| Mar 2006 | - | -$1.22 M(+40.6%) | -$3.82 M(+10.2%) |
| Dec 2005 | -$3.57 M(+27.3%) | -$866.00 K(0.0%) | -$3.46 M(+33.3%) |
| Sep 2005 | - | -$866.00 K(0.0%) | -$2.60 M(+50.0%) |
| Jun 2005 | - | -$866.00 K(0.0%) | -$1.73 M(+100.0%) |
| Mar 2005 | - | -$866.00 K | -$866.00 K |
| Dec 2004 | -$2.80 M(+194.2%) | - | - |
| Dec 2003 | -$953.00 K | - | - |
FAQ
- What is NovaBay Pharmaceuticals annual earnings before interest & taxes?
- What is the all time high annual EBIT for NovaBay Pharmaceuticals?
- What is NovaBay Pharmaceuticals annual EBIT year-on-year change?
- What is NovaBay Pharmaceuticals quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for NovaBay Pharmaceuticals?
- What is NovaBay Pharmaceuticals quarterly EBIT year-on-year change?
- What is NovaBay Pharmaceuticals TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for NovaBay Pharmaceuticals?
- What is NovaBay Pharmaceuticals TTM EBIT year-on-year change?
What is NovaBay Pharmaceuticals annual earnings before interest & taxes?
The current annual EBIT of NBY is -$5.00 M
What is the all time high annual EBIT for NovaBay Pharmaceuticals?
NovaBay Pharmaceuticals all-time high annual earnings before interest & taxes is $2.74 M
What is NovaBay Pharmaceuticals annual EBIT year-on-year change?
Over the past year, NBY annual earnings before interest & taxes has changed by +$2.68 M (+34.86%)
What is NovaBay Pharmaceuticals quarterly earnings before interest & taxes?
The current quarterly EBIT of NBY is -$1.07 M
What is the all time high quarterly EBIT for NovaBay Pharmaceuticals?
NovaBay Pharmaceuticals all-time high quarterly earnings before interest & taxes is $3.44 M
What is NovaBay Pharmaceuticals quarterly EBIT year-on-year change?
Over the past year, NBY quarterly earnings before interest & taxes has changed by -$376.00 K (-53.87%)
What is NovaBay Pharmaceuticals TTM earnings before interest & taxes?
The current TTM EBIT of NBY is -$6.75 M
What is the all time high TTM EBIT for NovaBay Pharmaceuticals?
NovaBay Pharmaceuticals all-time high TTM earnings before interest & taxes is $2.75 M
What is NovaBay Pharmaceuticals TTM EBIT year-on-year change?
Over the past year, NBY TTM earnings before interest & taxes has changed by -$790.00 K (-13.26%)